Cirrus Earplugs Looks To OTC Sleep Aids For Partnership
This article was originally published in The Tan Sheet
Executive Summary
After becoming the leading seller of brand and private-label earplugs, Cirrus Healthcare Products’ further growth depends on expanding the market for its products. CEO Drew O’Connell says he is talking with OTC firms about co-marketing products, with OTC sleep aids as good potential candidates.
You may also be interested in...
P&G Launches ZzzQuil To Enter OTC Sleep Aid Category
While other national brand names compete in the OTC sleep aid tablet category, P&G’s NyQuil line extension is by far the biggest name among current players in the liquid product category, which has annual growth of nearly 80%.
FDA Warns Matrixx On Combination Supplement/Drug Products
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
NanoBio Nasal Antiseptic Launch Accelerated As COVID-19 Spikes Demand For Personal Sanitizers
“When COVID-19 hit, we really decided to accelerate plans,” says BlueWillow CEO Dave Peralta. NanoBio Protect contains OTC monograph ingredient benzalkonium chloride in a proprietary nanotechnology, alcohol-free formulation to help reduce germs on skin inside and around the nose that could cause infections.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: